Article
Estrogen receptor α-mediated signaling inhibits type I interferon response to promote breast carcinogenesis
1 Jul 2023
Abstract excerpt
Estrogen receptor α (ERα) is an important driver and therapeutic target in ∼70% of breast cancers. How ERα drives breast carcinogenesis is not fully understood. In this study, we show that ERα is a negative regulator of type I interferon (IFN) response. Activation of ERα by its natural ligand estradiol inhibits IFN-β-induced transcription of downstream IFN-stimulated genes (ISGs), whereas ERα deficiency or the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
